Thymic tumors: Experience of the National Cancer Institute of Colombia
DOI:
https://doi.org/10.35509/01239015.17Keywords:
Thymoma, Thymus Neoplasms, Thymic carcinomaAbstract
Objectives: Thymic tumors have an overall incidence of 0.13 per 100,000 inhabitants, but they represent a significant percentage of mediastinal tumors. There is little literature based on our population, we make a contribution of our experience in the National Cancer Institute.
Methods: We did a case series study, reviewing the clinical histories of patients with thymic tumors treated at the National Cancer Institute from 2006 to 2017.
Results: From 2006 to 2017, 31 patients with thymic tumors such as thymoma, thymic hyperplasia, thymic cysts and thymic carcinomas were found, mainly in the female gender and with a median of 62 years of age. 2 patients presented Myasthenia Gravis (MG). 27 patients underwent thymectomy through sternotomy, video-thoracoscopy, thoracostomy among others, obtaining an overall survival greater than 90% at 5 years of follow-up. The stages of Masaoka I, II and III have a better prognosis than type IV regardless of the histological type.
Conclusions: Thymectomy is the first-line treatment in resectable cases, even when there is a compromise of nearby structures that allow a complete surgical resection. Our results describe behaviors and results similar to those found in the world literature
References
Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;(10 Suppl 4):S260-5.
International Thymic Malignancy Interest Group. About Thymoma [internet]. (citado diciembre de 2017). Available in: https://www.itmig.org/thymoma.
Scorsetti M, Leo F, Trama A, D’Angelillo R, Serpico D, Macerelli M, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332-50.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, et al. Thymomas and thymic carcino-mas. Natl Compr Cancer Netw. 2017;1:1-36.
Siwachat S, Tantraworasin A, Lapisatepun W, Ruen-gorn C, Taioli E, Saeteng S. Comparative clinical out-comes after thymectomy for myasthenia gravis: Tho-racoscopic versus trans-sternal approach. Asian J Surg [Internet]. 2016;(2016):1–9. Available from: http://dx-.doi.org/10.1016/j.asjsur.2016.09.006
Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Tay-lor WF. Thymoma. A Clinicopathologic Review. Cancer. 1987;60(11):2727-43.
Hakiri S, Kawaguchi K, Fukui T, Nakamura S, Ozeki N, Mori S, et al. Verification of the diagnostic strategy for anterior mediastinal tumors. Int J Clin Oncol [In-ternet]. 2018;0(0):0. Available from: http://dx.doi.org/10.1007/s10147-018-1362-8.
Giraldo, L. M., Duque, C., Uribe, C. S., & Hernán-dez, O. H. (2015). Síntomas de miastenia grave en un paciente con antecedente de timectomía por timo-ma invasor. Biomédica, 35(4), 475-9. https://doi.org/10.7705/biomedica.v35i4.2756
Hamaji M, Kojima F, Omasa M, Sozu T, Sato T, Chen F, et al. A meta-analysis of debulking surgery versus sur-gical biopsy for unresectable thymoma. Eur J Cardio-thorac Surg. 2015;47(4):602-7.
Sihvo E, Keshavjee S. 158: Transcervical Thymectomy. In: Sugarbaker DJ, Bueno R, Colson YL, Jaklitsch MT, Krasna MJ, Mentzer SJ (editors). Adult Chest Surgery. 2th edition. McGrawHill; 2015. p. 1254-9.
Argote-Greene LM, Jaklitsch MT, Sugarbaker DJ. 159: Thoracoscopic Approach to Thymectomy with Advice on Patients with Myasthenia Gravis. In: Sugarbaker DJ, Bueno R, Colson YL, Jaklitsch MT, Krasna MJ, Mentzer SJ (editors). Adult Chest Surgery. 2th edition. McGraw-Hill; 2015. p. 1260-5.
Qi K, Wang B, Wang B, Zhang L, Chu X. Video-assist-ed thoracoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis: a me-ta-analysis. 2016; 116(5):282-8.
D’Agostino HJ, Nussbaum MS. 160: Radical Transster-nal Thymectomy. In: Sugarbaker DJ, Bueno R, Col-son YL, Jaklitsch MT, Krasna MJ, Mentzer SJ (editors). Adult Chest Surgery. 2th edition. McGrawHill; 2015. p. 1301-11.
Xie A, Tjahjono R, Phan K, Yan TD. Video-assisted tho-racoscopic surgery versus open thymectomy for thy-moma: a systematic review. Ann Cardiothorac Surg. 2015;4(6):495-508.
Yacoub A, Gaitonde D, Wood J. Thymic hyperplasia and Graves disease: management of anterior medias-tinal masses in patients with Graves disease. Endoc Pract. 2009;15(6):534-9.
Ahmad U, Yao X, Detterbeck F, Huang J, Antonicel-li A, Filosso L, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Tho-rac Cardiovasc Surg. 2015;149(1):95-101.e2.
Leuzzi G, Rocco G, Ruffini E, Sperduti I, Detterbeck F, Weder W, et al. Multimodality therapy for locally ad-vanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database. J Thorac Cardiovasc Surg. 2016;151(1):47-57.e1.
Lim YJ, Kim E, Kim HJ, Wu HG, Yan J, Liu Q, et al. Survival impact of adjuvant radiation therapy in Ma-saoka stage ii to iv thymomas: A systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1129-36.
Fujii Y. Published guidelines for management of thy-moma. Thorac Surg Clin. 2011;21(1):125-9.
Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v40-55.
Huang J, Rizk NP, Travis WD, Riely GJ, Park BJ, Bains MS, et al. Comparison of Patterns of Relapse in Thymic Carcinoma and Thymoma. J Thorac Cardiovasc Surg. 2009;138(1):26-31.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
